On September 2, 2020 Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, reported that management will participate in two upcoming virtual investor conferences (Press release, Bellicum Pharmaceuticals, SEP 2, 2020, View Source [SID1234564322]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Details:

Wells Fargo 2020 Virtual Healthcare Conference
Date/Time: Wednesday, September 9, 2020 at 12:40 p.m. EDT
Format: Analyst Moderated Discussion

H.C. Wainwright 22nd Annual Global Investment Conference
Date/Time: Tuesday, September 15, 2020 at 2:30 p.m. EDT
Format: Presentation

A live webcast of the analyst moderated discussion session at Wells Fargo and the H.C. Wainwright presentation may be accessed from the Events & Presentation section of the Bellicum website. An archived version of each webcast will be available for replay immediately following the event.